SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: DEER HUNTER who wrote (753)4/19/1999 11:14:00 PM
From: JGoren  Read Replies (1) | Respond to of 1906
 
A bit amazed at the downturn in Amgen shares, but then the stock got ahead of itself. The whole pharmaceutical group went down, supposedly on the concern that earnings cannot keep pace with the stock prices. At the present price, Amgen looks pretty good although it does seem the pharmaceutical group is undergoing a revaluation. Long-term holder, at least ten years now.